EUVIMEDEUVIMED entdecken
Crossref

Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia

Suhong Zhang, Xin Tao, Minghui Fu, Yue Li, Gongbing Tu, Dianfu Zhang, Liping Yin iD

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Suhong Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Sarcopenia, STAT3 Transcription Factor, Wnt Signaling Pathway, Muscle Development. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Special Scientific and Technological Fund Project for the High-quality Development of Healthcare in Lishui District People's Hospital, Jiangsu Province Aged Health Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is a progressive disorder characterized by loss of skeletal muscle mass, strength, and function. Although STAT3 is known to regulate myogenic differentiation, its role in sarcopenia remains unclear.

Methods

STAT3 expression was assessed in skeletal muscle samples from sarcopenia patients and nonsarcopenic controls, as well as aged SAMP8 mice. C2C12 myoblasts were used to investigate the effects of STAT3 on proliferation and myogenic differentiation using gain‐ and loss‐of‐function approaches. The role of the Wnt/β‐catenin pathway was examined using pathway‐specific assays. In vivo, siRNA‐mediated STAT3 knockdown was performed in aged SAMP8 mice to evaluate effects on muscle phenotype and endurance.

Results

STAT3 expression was significantly upregulated in muscle tissues from sarcopenia patients and aged mice, correlating with increased expression of the atrophy marker MuRF‐1. STAT3 levels also rose during C2C12 cell differentiation. STAT3 overexpression suppressed C2C12 proliferation and myogenic differentiation, whereas knockdown enhanced both processes. Mechanistically, STAT3 inhibited Wnt/β‐catenin signaling, reducing the expression of myogenic markers. In vivo, STAT3 silencing in aged mice increased muscle mass, improved treadmill performance, and decreased muscle atrophy markers.

Conclusion

STAT3 impairs myogenic proliferation and differentiation by negatively regulating the Wnt/β‐catenin pathway, contributing to sarcopenia progression. Targeting STAT3 may serve as a promising therapeutic strategy for restoring muscle regeneration and function in sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaSTAT3 Transcription FactorWnt Signaling PathwayMuscle DevelopmentMuscle, Skeletalbeta CateninMyoblasts, SkeletalAnimalsHumansCell DifferentiationCell ProliferationMaleDisease Models, AnimalCell LineMiceUbiquitin-Protein LigasesFemaleAgedCase-Control StudiesTripartite Motif ProteinsPhenotypeAge FactorsMiddle AgedAged, 80 and overMuscle Proteins

Stichwörter der Autor:innen

C2C12STAT3Wnt/β‐cateninmuscle massmyogenic differentiationsarcopenia

Substanzen

STAT3 Transcription FactorStat3 protein, mouseSTAT3 protein, humanUbiquitin-Protein LigasesCTNNB1 protein, mouseTripartite Motif Proteinsbeta CateninTrim63 protein, mouseCTNNB1 protein, humanMuscle Proteins

Autor:innen und Institutionen

  • Department of Geriatrics, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.
  • Department of Orthopedics, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.

ORCID-Profile: Liping Yin

Förderung

  • Special Scientific and Technological Fund Project for the High-quality Development of Healthcare in Lishui District People's Hospital
  • Jiangsu Province Aged Health Research Project

Zitieren

APA

Zhang, S., Tao, X., Fu, M., Li, Y., Tu, G., Zhang, D., & Yin, L. (2025). Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70340

Vancouver

Zhang S, Tao X, Fu M, Li Y, Tu G, Zhang D, et al. Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70340

BibTeX
@article{Zhang2025,
  author = {Zhang, Suhong and Tao, Xin and Fu, Minghui and Li, Yue and Tu, Gongbing and Zhang, Dianfu and Yin, Liping},
  title = {Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70340}
}
Kostenlos starten →